Literature DB >> 2113317

Respiratory failure and sleep in neuromuscular disease.

P T Bye1, E R Ellis, F G Issa, P M Donnelly, C E Sullivan.   

Abstract

Sleep hypoxaemia in non-rapid eye movement (non-REM) and rapid eye movement (REM) sleep was examined in 20 patients with various neuromuscular disorders with reference to the relation between oxygen desaturation during sleep and daytime lung and respiratory muscle function. All the patients had all night sleep studies performed and maximum inspiratory and expiratory mouth pressures (PI and Pemax), lung volumes, single breath transfer coefficient for carbon monoxide (KCO), and daytime arterial oxygen (PaO2) and carbon dioxide tensions (PaCO2) determined. Vital capacity in the erect and supine posture was measured in 14 patients. Mean (SD) PI max at RV was low at 33 (19) cm H2O (32% predicted). Mean PE max at TLC was also low at 53 (24) cm H2O (28% predicted). Mean daytime PaO2 was 67 (16) mm Hg and PaCO2 52 (13) mm Hg (8.9 (2.1) and 6.9 (1.7) kPa). The mean lowest arterial oxygen saturation (SaO2) was 83% (12%) during non-REM and 60% (23%) during REM sleep. Detailed electromyographic evidence in one patient with poliomyelitis showed that SaO2% during non-REM sleep was maintained by accessory respiratory muscle activity. There was a direct relation between the lowest SaO2 value during REM sleep and vital capacity, daytime PaO2, PaCO2, and percentage fall in vital capacity from the erect to the supine position (an index of diaphragm weakness). The simple measurement of vital capacity in the erect and supine positions and arterial blood gas tensions when the patient is awake provide a useful initial guide to the degree of respiratory failure occurring during sleep in patients with neuromuscular disorders. A sleep study is required to assess the extent of sleep induced respiratory failure accurately.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2113317      PMCID: PMC473764          DOI: 10.1136/thx.45.4.241

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  20 in total

1.  A standardized breath holding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide.

Authors:  W S BLAKEMORE; R E FORSTER; J W MORTON; C M OGILVIE
Journal:  J Clin Invest       Date:  1957-01       Impact factor: 14.808

2.  Maximal respiratory pressures: normal values and relationship to age and sex.

Authors:  L F Black; R E Hyatt
Journal:  Am Rev Respir Dis       Date:  1969-05

3.  Do sleep studies contribute to the management of patients with severe chronic obstructive pulmonary disease?

Authors:  J J Connaughton; J R Catterall; R A Elton; J R Stradling; N J Douglas
Journal:  Am Rev Respir Dis       Date:  1988-08

4.  Fall in vital capacity with posture.

Authors:  S M Allen; B Hunt; M Green
Journal:  Br J Dis Chest       Date:  1985-07

5.  The accuracy of the Hewlett-Packard 47201A ear oximeter below 50% saturation.

Authors:  J R Stradling
Journal:  Bull Eur Physiopathol Respir       Date:  1982 Sep-Oct

6.  Hypoxemia during sleep in Duchenne muscular dystrophy.

Authors:  P E Smith; P M Calverley; R H Edwards
Journal:  Am Rev Respir Dis       Date:  1988-04

7.  Accessory muscle activity during sleep in chronic obstructive pulmonary disease.

Authors:  M W Johnson; J E Remmers
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1984-10

8.  Respiration during sleep in kyphoscoliosis.

Authors:  E H Sawicka; M A Branthwaite
Journal:  Thorax       Date:  1987-10       Impact factor: 9.139

9.  Nocturnal hypoxaemia in severe scoliosis.

Authors:  B Midgren; K Petersson; L Hansson; L Eriksson; P Airikkala; D Elmqvist
Journal:  Br J Dis Chest       Date:  1988-07

10.  The late sequelae of poliomyelitis.

Authors:  R S Howard; C M Wiles; G T Spencer
Journal:  Q J Med       Date:  1988-03
View more
  18 in total

1.  Disorders of Sleep and Breathing during Sleep in Neuromuscular Disease.

Authors:  Erik Van Lunteren; Henry J. Kaminski
Journal:  Sleep Breath       Date:  1999       Impact factor: 2.816

Review 2.  Long term ventilation in neurogenic respiratory failure.

Authors:  Robin S Howard; Craig Davidson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-09       Impact factor: 10.154

3.  Home mechanical ventilation: a Canadian Thoracic Society clinical practice guideline.

Authors:  Douglas A McKim; Jeremy Road; Monica Avendano; Steve Abdool; Fabien Cote; Nigel Duguid; Janet Fraser; Fracois Maltais; Debra L Morrison; Colleen O'Connell; Basil J Petrof; Karen Rimmer; Robert Skomro
Journal:  Can Respir J       Date:  2011 Jul-Aug       Impact factor: 2.409

Review 4.  [Residual neuromuscular blockades. Clinical consequences, frequency and avoidance strategies].

Authors:  T Fuchs-Buder; M Eikermann
Journal:  Anaesthesist       Date:  2006-01       Impact factor: 1.041

5.  Is chronic respiratory failure in neuromuscular diseases worth treating?

Authors:  J M Shneerson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-07       Impact factor: 10.154

6.  Pressure support versus assisted controlled noninvasive ventilation in neuromuscular disease.

Authors:  Karim Chadda; Bernard Clair; David Orlikowski; Gilles Macadoux; Jean Claude Raphael; Frédéric Lofaso
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

Review 7.  Sleep studies of respiratory function and home respiratory support.

Authors:  A K Simonds
Journal:  BMJ       Date:  1994-07-02

8.  Patterns and predictors of sleep disordered breathing in primary myopathies.

Authors:  R Ragette; U Mellies; C Schwake; T Voit; H Teschler
Journal:  Thorax       Date:  2002-08       Impact factor: 9.139

Review 9.  Respiratory aspects of neurological disease.

Authors:  M I Polkey; R A Lyall; J Moxham; P N Leigh
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-01       Impact factor: 10.154

10.  Sleep hypoxia in myotonic dystrophy and its correlation with awake respiratory function.

Authors:  A J Finnimore; R V Jackson; A Morton; E Lynch
Journal:  Thorax       Date:  1994-01       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.